Scholar Rock Holding Corp (SRRK) stock
SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$45.08+0.54 (+1.21%)
Close on Nov 17, 2026Market cap $5.49BP/E –Yield –
Scholar Rock total assets
Total assets on the balance sheet at the end of each period.
Scholar Rock's total assets was $523.54M at Jun 30, 2026. For fiscal 2025 it was $404.27M, down 14.9% from the year before. The highest annual figure on record is $474.92M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $404.27M | -14.9% |
| FY2024 | Dec 31, 2024 | $474.92M | +52.7% |
| FY2023 | Dec 31, 2023 | $311.04M | -13.2% |
| FY2022 | Dec 31, 2022 | $358.17M | +17.6% |
| FY2021 | Dec 31, 2021 | $304.45M | -21.6% |
| FY2020 | Dec 31, 2020 | $388.31M | +97.7% |
| FY2019 | Dec 31, 2019 | $196.38M | +8.3% |
| FY2018 | Dec 31, 2018 | $181.34M | +194.2% |
| FY2017 | Dec 31, 2017 | $61.64M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $523.54M | +54.0% |
| Q1 FY2026 | Mar 31, 2026 | $535.25M | +31.3% |
| Q4 FY2025 | Dec 31, 2025 | $404.27M | -14.9% |
| Q3 FY2025 | Sep 30, 2025 | $411.72M | +129.8% |
| Q2 FY2025 | Jun 30, 2025 | $340.05M | +49.9% |
| Q1 FY2025 | Mar 31, 2025 | $407.55M | +52.5% |
| Q4 FY2024 | Dec 31, 2024 | $474.92M | +52.7% |
| Q3 FY2024 | Sep 30, 2024 | $179.13M | -28.5% |
| Q2 FY2024 | Jun 30, 2024 | $226.87M | -20.4% |
| Q1 FY2024 | Mar 31, 2024 | $267.29M | -15.1% |
| Q4 FY2023 | Dec 31, 2023 | $311.04M | -13.2% |
| Q3 FY2023 | Sep 30, 2023 | $250.69M | -35.8% |
| Q2 FY2023 | Jun 30, 2023 | $284.90M | -32.8% |
| Q1 FY2023 | Mar 31, 2023 | $314.72M | +18.3% |
| Q4 FY2022 | Dec 31, 2022 | $358.17M | +17.6% |
| Q3 FY2022 | Sep 30, 2022 | $390.30M | +30.8% |
| Q2 FY2022 | Jun 30, 2022 | $424.13M | +27.7% |
| Q1 FY2022 | Mar 31, 2022 | $265.98M | -26.2% |
| Q4 FY2021 | Dec 31, 2021 | $304.45M | -21.6% |
| Q3 FY2021 | Sep 30, 2021 | $298.39M | +82.6% |
| Q2 FY2021 | Jun 30, 2021 | $332.05M | +112.4% |
| Q1 FY2021 | Mar 31, 2021 | $360.59M | +105.2% |
| Q4 FY2020 | Dec 31, 2020 | $388.31M | +97.7% |
| Q3 FY2020 | Sep 30, 2020 | $163.42M | -13.3% |
| Q2 FY2020 | Jun 30, 2020 | $156.36M | -20.6% |
| Q1 FY2020 | Mar 31, 2020 | $175.70M | +2.8% |
| Q4 FY2019 | Dec 31, 2019 | $196.38M | +8.3% |
| Q3 FY2019 | Sep 30, 2019 | $188.54M | +72.9% |
| Q2 FY2019 | Jun 30, 2019 | $196.91M | +65.5% |
| Q1 FY2019 | Mar 31, 2019 | $170.98M | +177.4% |
| Q4 FY2018 | Dec 31, 2018 | $181.34M | – |
| Q3 FY2018 | Sep 30, 2018 | $109.02M | – |
| Q2 FY2018 | Jun 30, 2018 | $118.98M | – |
| Q4 FY2017 | Dec 31, 2017 | $61.64M | – |
See a number that looks wrong?